-+ 0.00%
-+ 0.00%
-+ 0.00%

Gaush Meditech expects H1 revenue RMB 583.2 million-RMB 607 million, down 7.1%-10.7%

PUBT·08/03/2026 10:35:19
Listen to the news
Gaush Meditech expects H1 revenue RMB 583.2 million-RMB 607 million, down 7.1%-10.7%
  • Gaush Meditech issued a supplemental profit warning, flagging 1H 2026 revenue of RMB 583.2 million to RMB 607 million.
  • That compares with RMB 653.1 million a year earlier, implying a 7.1% to 10.7% decline.
  • Interim results remain in progress, with publication expected by end-August 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gaush Meditech Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260803-12269115), on August 03, 2026, and is solely responsible for the information contained therein.